2023
Arnold WA, Blum A, Branyan J, Bruton TA, Carignan CC, Cortopassi G, Datta S, DeWitt J, Doherty A, Halden RU, Harari H, Hartmann EM, Hrubec TC, Iyer S, Kwiatkowski CF, LaPier J, Li D, Li L, Ortiz JGM, Salamova A, Schettler T, Seguin RP, Soehl A, Sutton R, Xu L, Zheng G
Quaternary Ammonium Compounds: A Chemical Class of Emerging Concern
2023
Amorim R, Magalhães CC, Benfeito S, Cagide F, Tavares LC, Santos K, Sardão VA, Datta S, Cortopassi GA, Baldeiras I, Jones JG, Borges F, Oliveira PJ, Teixeira J
Mitochondria dysfunction induced by decyl-TPP mitochondriotropic antioxidant based on caffeic acid AntiOxCIN6 sensitizes cisplatin lung anticancer therapy due to a remodeling of energy metabolism
2022
Lee ES, Chun KC, Gupta A, Anderson RC, Irwin ZT, Newton EA, Jamie-Hughes N, Datta S^
Costs of Abdominal Aortic Aneurysm (AAA) Care at a Regional Veterans Affairs Medical Center with the Implementation of an AAA Screening Program
2021
Gupta A, Kindarara D, Chun KC, Datta S, Anderson RC, Irwin ZT, Newton EA, Lee ES
Accuracy of Point-of-Care Ultrasound in Follow up Abdominal Aortic Aneurysm Imaging
2021
Hrubec TC, Seguin RP, Xu L, Cortopassi GA, Datta S, Hanlon AL, Lozano AJ, McDonald VA, Healy CA, Anderson TC, Musse NA, Williams RT
Altered toxicological endpoints in humans from common quaternary ammonium compound disinfectant exposure
2021
Datta S, Sears T, Cortopassi G, Woolard K, Angelastro JM
Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells
2020
Sandoval JA, Tomilov A, Datta S, Allen S, O'Donnell R, Sears T, Woolard K, Kovalskyy D, Angelastro JM, Cortopassi G
Novel mTORC1 Inhibitors Kill Glioblastoma Stem Cells
2019
Crakes KR, Rocha CS, Grishina I, Hirao LA, Napoli E, Gaulke CA, Fenton A, Datta S, Arredondo J, Marco ML, Sankaran-Walters S, Cortopassi GA, Giulivi C, Dandekar S
PPARa-targeted mitochondrial bioenergetics mediate repair of intestinal barriers at the host-microbe intersection during SIV infection
2019
Allen SA, Datta S^, Sandoval J, Tomilov A, Sears T, Woolard K, Angelastro JM, Cortopassi GA
Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer
2018
Teixeira J, Amorim R, Santos K, Soares P, Datta S, Cortopassi GA, Serafim TL, Sardão VA, Garrido J, Borges F, Oliveira PJ
Disruption of mitochondrial function as mechanism for anti-cancer activity of a novel mitochondriotropic menadione derivative.